SPL UNCLASSIFIED SECTION
Chlortetracycline
Sulfamethazine
Type A Medicated Article
Chlortetracycline
Sulfamethazine
Type A Medicated Article
| Active Drug Ingredients: | Chlortetracycline calcium complex equivalent to Chlortetracycline HCl | 40 g/lb. | |
| Sulfamethazine | 8.8% (40 g/lb.) | ||
| Ingredients: Calcium carbonate, Roughage Products and Mineral Oil | |||
| For Use in the Manufacture of Medicated Swine Feeds | |||
| Indications | For reduction of the incidence of cervical abscesses; treatment of bacterial swine enteritis (salmonellosis or necrotic enteritis caused by Salmonella choleraesuis and vibrionic dysentery); prevention of bacterial swine enteritis (salmonellosis or necrotic enteritis caused by Salmonella choleraesuis and vibrionic dysentery) during times of stress; maintenance of weight gains in the presence of atrophic rhinitis. | ||
| Directions For Use | |||
| Mix 2.5 lbs. of Article with part of the feed ingredients to make a preblend. Add the remainder of the ingredients to give a final concentration of 100g chlortetracycline, and 100g sulfamethazine per ton of Type C feed and mix thoroughly. | |||
| WARNING: WITHDRAW 15 DAYS PRIOR TO SLAUGHTER | |||
| Approved by FDA under NADA # 138-934 | |||
Marketed by:
PHARMGATE ANIMAL HEALTH, LLC
14040 Industrial Road
Omaha, Nebraska 68144
Take TimeObserve Directions
Pennchlor® S 40/40™
Chlortetracycline
Sulfamethazine
Type A Medicated Article
CAUTION: Federal law restricts medicated feed containing this
veterinary feed directive (VFD) drug to use by or on the order of a
licensed veterinarian.
See mixing directions, claims, cautions and warnings on back.
Restricted Drug (California) - Use Only as Directed.
Not For Human Use.
Net wt. 50 LB (22.68 Kg)
Pharmgate
ANIMAL HEALTH

| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Chlortetracycline Calcium | ACTIVE INGREDIENT | NR4B2SX17S | 1 | |
| Penicillin G Procaine | ACTIVE INGREDIENT | 17R794ESYN | 1 | |
| Sulfamethazine | ACTIVE INGREDIENT | 48U51W007F | 1 | |
| Chlortetracycline | ACTIVE MOIETY | WCK1KIQ23Q | 1 | |
| Penicillin G | ACTIVE MOIETY | Q42T66VG0C | 1 | |
| Sulfamethazine | ACTIVE MOIETY | 48U51W007F | 1 | |
| Calcium Carbonate | INACTIVE INGREDIENT | H0G9379FGK | 1 | |
| Mineral Oil | INACTIVE INGREDIENT | T5L8T28FGP | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 51429-500 | 51429-500-06 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Chlortetracycline Calcium | NR4B2SX17S | ACTIR |
| Sulfamethazine | 48U51W007F | ACTIB |
| Calcium Carbonate | H0G9379FGK | IACT |
| Mineral Oil | T5L8T28FGP | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Mineral Oil | MINERAL OIL | T5L8T28FGP | TABLET, CHEWABLE / ORAL | 6 mg | ||
| Calcium Carbonate | CALCIUM CARBONATE | H0G9379FGK | TABLET, EXTENDED RELEASE / ORAL | 229.7 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | OINTMENT / TOPICAL | 9938 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | SYSTEM / TRANSDERMAL | 6.09 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | OINTMENT / OPHTHALMIC | 59.5 %w/w | ||
| Calcium Carbonate | CALCIUM CARBONATE | H0G9379FGK | TABLET, CHEWABLE / ORAL | 1650 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | SPRAY / TOPICAL | 1379 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | SUSPENSION / OPHTHALMIC | 0.1 %w/w | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | SUPPOSITORY / RECTAL | NA | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | FILM, EXTENDED RELEASE / TRANSDERMAL | 34 mg | ||
| Calcium Carbonate | CALCIUM CARBONATE | H0G9379FGK | TABLET, FILM COATED / ORAL | 300 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | TABLET, FILM COATED / ORAL | NA | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | TABLET / ORAL | 113.75 mg | ||
| Calcium Carbonate | CALCIUM CARBONATE | H0G9379FGK | GUM, CHEWING / BUCCAL | 3492 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | PASTE / TOPICAL | 47.5 %w/w | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | SYSTEM / TOPICAL | 654.36 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | LOTION / TOPICAL | 1428 mg | ||
| Calcium Carbonate | CALCIUM CARBONATE | H0G9379FGK | POWDER, DENTIFRICE / DENTAL | 0.5 mg/mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | OIL / TOPICAL | 43.29 %v/v | ||
| Calcium Carbonate | CALCIUM CARBONATE | H0G9379FGK | TABLET / ORAL | 793 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | CAPSULE, EXTENDED RELEASE / ORAL | 120 mg | ||
| Calcium Carbonate | CALCIUM CARBONATE | H0G9379FGK | CAPSULE / ORAL | 349.9 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | SOAP / TOPICAL | 0.82 %w/w | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | CREAM / TOPICAL | 2772 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | SUPPOSITORY / VAGINAL | 30 mg | ||
| Calcium Carbonate | CALCIUM CARBONATE | H0G9379FGK | TABLET, DELAYED RELEASE / ORAL | 8.4 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | TABLET, DELAYED RELEASE / ORAL | 5.67 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | SUSPENSION / AURICULAR (OTIC) | 0.5 %w/v | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | CAPSULE / ORAL | 120 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | OINTMENT / AURICULAR (OTIC) | NA | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | DROPS / ORAL | NA | ||
| Calcium Carbonate | CALCIUM CARBONATE | H0G9379FGK | CAPSULE, DELAYED RELEASE / ORAL | 20 mg | ||
| Calcium Carbonate | CALCIUM CARBONATE | H0G9379FGK | FILM, SOLUBLE / ORAL | 14 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | PASTE / DENTAL | 95 %w/w | ||
| Calcium Carbonate | CALCIUM CARBONATE | H0G9379FGK | SOLUTION / INTRAVENOUS | 4.02 %w/v | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | GEL / TOPICAL | 2.5 %w/w | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | CREAM / VAGINAL | 402 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | TABLET, EXTENDED RELEASE / ORAL | NA | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | SUSPENSION / TOPICAL | 82 %w/w | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | FILM / TRANSDERMAL | 11.42 mg | ||
| Calcium Carbonate | CALCIUM CARBONATE | H0G9379FGK | SOLUTION / AURICULAR (OTIC) | 0.38 %w/w | ||
| Calcium Carbonate | CALCIUM CARBONATE | H0G9379FGK | SOLUTION / RESPIRATORY (INHALATION) | 4.02 %w/v | ||
| Calcium Carbonate | CALCIUM CARBONATE | H0G9379FGK | CAPSULE, EXTENDED RELEASE / ORAL | 4 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | TABLET, COATED / ORAL | 1.5 mg | ||
| Calcium Carbonate | CALCIUM CARBONATE | H0G9379FGK | TABLET, COATED / ORAL | 64.8 mg |
Adverse event summaries are temporarily unavailable. Other product information remains available.